Coronavirus Disease 2019 in Neonates - What Is Known and What Needs to Be Known
- PMID: 33029451
- PMCID: PMC7529492
- DOI: 10.7759/cureus.10171
Coronavirus Disease 2019 in Neonates - What Is Known and What Needs to Be Known
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Wuhan, China, and subsequently spread worldwide affecting all ages including newborns. The cases of coronavirus disease 2019 (COVID-19) are very less in neonates and they recover well with supportive treatment. Though the vertical transmission of infection is scarcely found, to get rid of acquiring infection by horizontal transmission one should screen all pregnant women and ensure standard infection control measures and monitoring of newborns at risk of COVID-19. Neonates may present as a refusal to feed, feeding intolerance, fever, pneumonia, shortness of breath, and lethargic. Based on available evidence, antivirals like lopinavir, ritonavir, remdesivir specific medication like chloroquine/hydroxychloroquine, azithromycin, corticosteroids, and intravenous gamma globulin, are not recommended, so early detection and supportive treatment is needed for an optimal outcome.
Keywords: covid-19; newborn; sars cov-2; vertical transmission.
Copyright © 2020, Nayak et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Coronavirus disease 2019 (COVID-19) during pregnancy: a case series. Liu W, Wang Q, Zhang Q, et al. https://www.preprints.org/manuscript/202002.0373/v1 Preprints. 2020
-
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Chen H, Guo J, Wang C, et al. https://doi.org/10.1016/S0140-6736(20)30360-3. Lancet. 2020;395:809–815. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous